Mavyret is a fixed dose combination of the direct-acting antiviral agents, glecaprevir, a HCV NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical ...

HealthDay News — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

A longtime vaccine critic hired by Health Secretary Robert F. Kennedy Jr. is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.